首页 > 市场调查报告书 > 医疗设备

生技设备

切片检查设备市场规模、份额和成长分析（按产品、引导技术、应用、最终用途和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1896782

切片检查设备市场规模、份额和成长分析（按产品、引导技术、应用、最终用途和地区划分）—2026-2033年产业预测

Biopsy Devices Market Size, Share, and Growth Analysis, By Product, By Guidance Technique, By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，切片检查设备市场规模将达到 75.2 亿美元，到 2025 年将达到 85.8 亿美元，到 2033 年将达到 244.7 亿美元，预测期（2026-2033 年）的复合年增长率为 14%。

切片检查设备市场的发展主要受各种癌症发生率上升和技术融合程度提高的驱动。作为诊断癌症和乳糜泻等疾病的关键外科手术，切片检查设备，尤其是肝臟、肾臟和肺等器官切片检查所需的专业活检仪器，需求旺盛。 CT电脑断层扫描、MRI和超音波等先进影像技术的融合提高了活检的准确性，并最大限度地减少了切片检查的侵入性。 3D光学切片和MRI靶向切片检查等新兴技术备受关注，并推动了诊断精准度的提升。然而，切片检查设备高成本以及发展中地区缺乏训练有素的专业人员等挑战依然存在，这些都可能阻碍市场成长。

全球切片检查设备市场按产品、引导技术、应用、最终用户和地区进行细分。按产品划分，市场分为液态生物检体设备、针式切片检查设备、手术托盘、立体定位导丝、切片检查台、切片检查钳和其他产品。依引导技术划分，市场分为非影像引导切片检查和影像引导切片检查技术。依应用划分，市场分为肺癌、乳癌、大肠癌、肾癌、摄护腺癌、骨髓切片检查和其他应用。按最终用户划分，市场分为医院和乳房护理中心、诊断影像中心、学术和研究机构以及其他最终用户。按地区划分，市场分为北美、欧洲、亚太、中东和非洲以及拉丁美洲。

切片检查设备市场驱动因素

全球癌症发生率的不断上升是切片检查设备市场成长的主要驱动力。随着癌症发生率的增加，对精准早期诊断工具的需求也随之增长，凸显了及时介入患者照护的必要性。这种对切片检查需求的成长推动了创新切片检查设备的研发和应用，从而促进了市场成长。对有效诊断和改进治疗方法的迫切需求，为该领域先进技术的发展创造了有利环境，提高了医疗机构中切片检查设备的整体可用性和利用率。

切片检查设备市场的限制

许多发展中地区尖端切片检查技术的普及程度有限，严重限制了切片检查设备市场的成长。经济挑战和医疗基础设施落后共同限制了现代切片检查设备的供应和应用。这种资源匮乏不仅影响了设备的即时使用，也阻碍了市场的整体扩张，因为这些地区的医疗服务提供者面临着阻碍先进诊断工具普及的许多障碍。因此，这些因素严重阻碍因素了服务不足地区切片检查设备市场的发展和潜力。

切片检查设备市场趋势

由于超音波和电脑断层扫描等影像导引切片检查技术具有高精度和即时成像功能，其应用已成为切片检查设备市场的一大趋势。这项技术进步不仅提高了诊断准确率，也对患者预后产生了正面影响。随着医疗机构逐渐认识到这些创新技术的优势，对先进切片检查设备的需求预计将大幅增长。微创手术的趋势，以及精准诊断在肿瘤学和其他领域日益增长的重要性，正在推动市场成长并改变切片检查设备的模式。

液态生物检体装置
针式切片检查装置
- 核心切片检查装置
- 核心切片穿刺针
- 核心切片检查枪
- 抽吸切片穿刺针
- 真空辅助切片检查装置
- 真空辅助切片检查系统
- 真空辅助切片穿刺针
治疗托盘
位置确认线
切片检查
切片检查钳
- 普通切片检查钳
- 高温切片检查钳
其他产品

按引导技术分類的切片检查设备市场

非影像引导切片检查
影像引导切片检查
- 超音波引导下切片检查
- 立体定位引导切片检查
- 磁振造影引导切片检查
- 其他影像引导切片检查技术

按应用分類的切片检查设备市场

肺癌
乳癌
大肠直肠癌
肾癌
摄护腺癌
骨髓切片检查
其他用途

按最终用户分類的切片检查设备市场

医院及乳房护理中心
诊断影像中心
学术和研究机构
其他最终用户

按地区分類的切片检查设备市场规模

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Becton, Dickinson and Company（US）
Danaher Corporation（US）
B. Braun Melsungen AG（Germany）
Cardinal Health, Inc.（US）
Hologic, Inc.（US）
Olympus Corporation（Japan）
Boston Scientific Corporation（US）
Fujifilm Corporation（Japan）
Medtronic Plc（Ireland）
Stryker Corporation（US）
Cook Group Incorporated（US）
Argon Medical Devices（US）
Inrad, Inc.（US）
Conmed Corporation（US）
Teleflex Incorporated（US）
Qiagen NV（Netherlands）
Thermo Fisher Scientific, Inc.（US）
Summit Medical LLC（US）
Hill-Rom Holdings, Inc.（US）
Gallini SRL（Italy）
Transmed7, LLC（US）
TSK Laboratory International（Japan）
Merit Medical Systems, Inc.（US）
DR. Japan Co., Ltd.（Japan）
IZI Medical Products（US）
Planmed Oy（Finland）
Advin Health Care（India）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Illumina, Inc.（US）

简介目录

Product Code: SQMIG35A2955

Biopsy Devices Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.58 Billion in 2025 to USD 24.47 Billion by 2033, growing at a CAGR of 14% during the forecast period (2026-2033).

The biopsy devices market is driven by the increasing prevalence of various cancers and advancements in technological integration. As a critical surgical method for diagnosing diseases like cancer and coeliac disease, the demand for specialized biopsy instruments is robust, particularly for organ biopsies of the liver, kidneys, and lungs. The incorporation of advanced imaging technologies such as CT scans, MRIs, and ultrasound enhances the precision and minimizes the invasiveness of biopsy procedures. Emerging methods like 3D optical and MRI-targeted biopsies are gaining traction, supporting the trend towards more accurate diagnostics. However, challenges remain, including the high cost of biopsy equipment and a shortage of trained professionals in developing regions, which can impede market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopsy Devices Market Segments Analysis

Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Biopsy Devices Market

The biopsy devices market is largely propelled by the rising occurrence of cancer worldwide. As cancer rates escalate, the demand for accurate and early diagnostic tools intensifies, highlighting the necessity for timely intervention in patient care. This increasing requirement for biopsies fuels the advancement and adoption of innovative biopsy devices, thus driving market growth. The urgency for effective diagnostics and improved treatment options creates a flourishing environment for the development of advanced technologies in this sector, thereby enhancing the overall landscape of biopsy device offerings and their utilization in medical practices.

Restraints in the Biopsy Devices Market

The growth of the biopsy devices market is significantly impeded in numerous developing regions due to restricted access to cutting-edge biopsy technologies. Economic challenges coupled with underdeveloped healthcare infrastructures limit both the availability and adoption of modern biopsy instruments. This lack of accessibility not only affects the immediate use of such devices but also influences their overall market expansion, as healthcare providers in these areas face barriers that prevent the integration of advanced diagnostic tools. Consequently, these factors create a notable restraint in the progression and potential of the biopsy devices market in these underserved locations.

Market Trends of the Biopsy Devices Market

The Biopsy Devices market is witnessing a notable trend towards the adoption of image-guided biopsy techniques, such as ultrasound and CT scan guidance, due to their enhanced accuracy and real-time imaging capabilities. This technological advancement is not only improving diagnostic precision but also positively impacting patient outcomes. As healthcare providers increasingly recognize the benefits of these innovative methods, the demand for advanced biopsy equipment is expected to surge. This shift towards minimally invasive procedures, combined with a growing emphasis on precise diagnostics in oncology and other fields, is propelling growth and transforming the biopsy device landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Technology Analysis
Case Study Analysis
Pricing Analysis

Biopsy Devices Market, By Product

Market Overview
Liquid Biopsy Instruments
Needle-Based Biopsy Instruments
- Core Biopsy Devices
- Core Biopsy Needles
- Core Biopsy Guns
- Aspiration Biopsy Needles
- Vacuum-Assisted Biopsy Devices
- Vacuum-Assisted Biopsy Systems
- Vacuum-Assisted Biopsy Needles
Procedure Trays
Localization Wires
Biopsy Tables
Biopsy Forceps
- General Biopsy Forceps
- Hot Biopsy Forceps
Other Products

Biopsy Devices Market, By Guidance Technique

Market Overview
Non-Image-Guided Biopsy
Image-Guided Biopsy
- Ultrasound-Guided Biopsy
- Stereotactic-Guided Biopsy
- Mri-Guided Biopsy
- Other Image-Guided Biopsy Techniques

Biopsy Devices Market, By Application

Market Overview
Lung Cancer
Breast Cancer
Colorectal Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Other Applications

Biopsy Devices Market, By End User

Market Overview
Hospitals & Breast Care Centers
Diagnostic Imaging Centers
Academic & Research Institutes
Other End Users

Biopsy Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Group Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inrad, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Summit Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hill-Rom Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gallini S.R.L (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transmed7, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSK Laboratory International (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DR. Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IZI Medical Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advin Health Care (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments